Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.
Phlox Therapeutics's investors include ROM Utrecht Region, NWO, Utrecht Health Seed Fund, Amsterdam UMC Ventures, First.
Phlox Therapeutics is headquartered in Naarden, The Netherlands.
Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.
Phlox Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phlox Therapeutics — Funding & Investors." VCBacked, November 13, 2024, https://www.vcbacked.co/company/phlox-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Phlox Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/phlox-therapeutics
{{cite web |title=Phlox Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/phlox-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated